The four centres with the facilities and expertise to give prolonged PN beyond term and provide paediatric ( < 16 years of age) HPN are formalised within the Scottish HPN MCN. Scotland comprises 8.6 % of the UK paediatric population. We aimed to demonstrate incidence and prevalence of the need for paediatric HPN in Scotland, as a representative part of the UK. We report nationwide incidence and prevalence of paediatric HPN in Scotland, from the 4 centres. Extrapolation to the UK suggests that there are annual minimum paediatric incidences and period prevalence of 48 and 126 cases. Standardised 2010 point prevalence and incidence rates of 12.1 and 5.5 per million compare with and validate the 13.7 and 6.0 per million respectively from a recent UK survey (1) ; however our period prevalence data suggests a higher rate of 15.4 per million.
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